Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.

Tzao, C; Jin, J-S; Chen, B-H; Chung, H-Y; Chang, C-C; Hsu, T-Y; Sun, G-H

Tzao, C; Jin, J-S; Chen, B-H; Chung, H-Y; Chang, C-C; Hsu, T-Y; Sun, G-H.

Affiliation

Tzao C; Division of Thoracic Surgery, Tri-Service General Hospital, Taichung, Taiwan; Department and Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taichung, Taiwan.

Dis Esophagus ; 27(7): 693-702, 2014.

Article in En | MEDLINE | ID: mdl-24033428

Subject(s)

Antineoplastic Agents/pharmacology; Apoptosis/drug effects; Carcinoma, Squamous Cell; Cell Cycle Checkpoints/drug effects; Cell Proliferation/drug effects; Esophageal Neoplasms; Hydroxamic Acids/pharmacology; Animals; Cell Line, Tumor; Cell Survival/drug effects; Esophageal Squamous Cell Carcinoma; Female; Humans; In Vitro Techniques; Mice; Mice, Nude; Vorinostat; Xenograft Model Antitumor Assays

Key words

apoptosis; cell cycle arrest; esophageal squamous cell cancer; histone deacetylase (HDAC); suberoylanilide hydroxamic acid (SAHA)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Apoptosis / Cell Proliferation / Cell Cycle Checkpoints / Hydroxamic Acids / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: Dis Esophagus Journal subject: GASTROENTEROLOGIA Year: 2014 Document type: Article Affiliation country: Taiwan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google